Brought to you by 
FOPO brings in $28.4mm for glucose monitoring firm DexCom
02 Dec 2010
Executive Summary
DexCom Inc. (glucose monitoring devices) has netted $28.4mm through the public sale of 2.85mm common shares at $10.13 each.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com